XML 38 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows From Operating Activities:      
Net income $ 168,353 $ 227,497 $ 234,196
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 174,474 163,438 154,208
Amortization of debt issuance costs and discounts 4,385 4,978 6,131
Loss on early extinguishment of debt and write-off of discounts and debt issuance costs   5,544  
Deferred income tax provision 49,054 50,694 72,636
Equity-based compensation 17,233 13,673 17,032
Other including loss on impairment or disposal of assets, net 31,282 33,816 30,523
Changes in assets and liabilities:      
Accounts receivable 5,036 (10,926) (4,528)
Inventories (8,628) 2,597 5,366
Prepaid expenses and other current assets (23,644) (7,727) 9,448
Accounts payable and accrued expenses (9,339) 13,248 (8,887)
Accrued salaries, wages and benefits 4,380 1,462 3,781
Deferred revenue (13,734) 475 (13,953)
Other accrued liabilities (15,726) (15,297) 5,608
Right-of-use assets and operating lease liabilities 412 596 439
Other assets and liabilities (3,453) (3,929) (7,084)
Net cash provided by operating activities 380,085 480,139 504,916
Cash Flows From Investing Activities:      
Capital expenditures (217,489) (248,430) (304,836)
Other investing activities   (75) (771)
Net cash used in investing activities (217,489) (248,505) (305,607)
Cash Flows From Financing Activities:      
Proceeds from the issuance of debt, net   378,295  
Repayments of long-term debt (15,423) (242,058) (12,000)
Proceeds from draw on revolving credit facility     20,000
Repayments of revolving credit facility     (20,000)
Purchase of treasury stock, including related excise tax paid (160,413) (482,922) (17,861)
Payment of tax withholdings on equity-based compensation through shares withheld (2,540) (8,756) (6,859)
Exercise of stock options 1,133 1,792 2,940
Debt issuance costs   (7,780)  
Other financing activities (1,484) (1,234) (927)
Net cash used in financing activities (178,727) (362,663) (34,707)
Change in Cash and Cash Equivalents, including Restricted Cash (16,131) (131,029) 164,602
Cash and Cash Equivalents, including Restricted Cash—Beginning of year 115,893 246,922 82,320
Cash and Cash Equivalents, including Restricted Cash—End of year 99,762 115,893 246,922
Supplemental Disclosures of Noncash Investing and Financing Activities      
Capital expenditures in accounts payable and accrued expenses 41,420 40,583 $ 50,618
Excise tax accrued on treasury stock repurchases 1,455 $ 4,608  
Treasury stock purchases not yet settled in accounts payable and accrued expenses $ 1,174